Cizzle Biotechnology (LON:CIZ) Posts Earnings Results

Cizzle Biotechnology (LON:CIZ) released its earnings results on Tuesday. The company reported GBX (0.17) earnings per share for the quarter, Digital Look Earnings reports.

Cizzle Biotechnology Trading Up 2.3%

CIZ stock opened at GBX 2.66 on Wednesday. The business has a fifty day moving average of GBX 2.02 and a 200-day moving average of GBX 1.72. The company has a market cap of £10.54 million, a P/E ratio of -15.65 and a beta of 0.51. The company has a quick ratio of 4.66, a current ratio of 0.48 and a debt-to-equity ratio of -54.35. Cizzle Biotechnology has a twelve month low of GBX 1.20 and a twelve month high of GBX 3.30.

Cizzle Biotechnology Company Profile

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.